Market Overview

Global Human Milk Oligosaccharides (HMO) Market size and share is currently valued at USD 255.86 million in 2024 and is anticipated to generate an estimated revenue of USD 1,821.29 million by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 22.60% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034

The Human Milk Oligosaccharides (HMO) market is witnessing significant growth as awareness of infant nutrition and immunity continues to rise globally. HMOs are complex carbohydrates naturally found in human breast milk and are recognized for their ability to support gut health, strengthen the immune system, and promote overall infant development. These compounds are increasingly being incorporated into infant formulas, functional foods, dietary supplements, and nutraceuticals to mimic the benefits of natural breast milk.

Growing health awareness, rising birth rates in certain regions, and increasing adoption of infant formula in urban populations are driving the demand for HMOs. Additionally, research highlighting the role of HMOs in gut microbiota modulation and disease prevention has strengthened market potential. Manufacturers are investing in biotechnology and synthetic production methods to meet rising demand and ensure consistent quality and supply.

Key Market Growth Drivers

Several factors are driving the expansion of the HMO market:

• Rising awareness of infant nutrition: Parents are increasingly prioritizing products that provide immunity and digestive health benefits.
• Increasing adoption of infant formulas: Urbanization and dual-income households contribute to the preference for formula-based feeding.
• Scientific research and clinical validation: Studies highlighting the benefits of HMOs in gut health and immunity boost consumer confidence.
• Biotechnological advancements: Innovations in synthetic production of HMOs allow scalable and cost-effective manufacturing.
• Expansion into functional foods and supplements: HMOs are being integrated into a wider range of products beyond infant nutrition.

𝐌𝐚𝐣𝐨𝐫 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

• Abbott Laboratories
• BASF S.E.
• Biosynth Carbosynth
• Chr. Hansen Holding A/S
• Dextra Laboratories Ltd.
• Dupont Nutrition & Biosciences
• Elicityl S.A.
• Glycosyn
• Inbiose NV
• Medolac Laboratories
• Neolacta Lifesciences Pvt. Ltd.
• Nestle Health Science
• Royal DSM
• Royal FrieslandCampina N.V.
• ZuChem

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/human-milk-oligosaccharides-hmo-market

Market Challenges and Opportunities

Challenges:

• High production costs associated with synthetic HMO manufacturing.
• Regulatory approvals and strict safety standards for infant nutrition products.
• Limited consumer awareness in developing regions.
• Complex supply chain requirements to maintain product quality and stability.

Opportunities:

• Growing demand for HMO-fortified infant formulas in emerging markets.
• Expansion of functional foods and nutraceuticals containing HMOs for adults.
• Rising interest in prebiotics and gut health supplements, leveraging HMOs’ health benefits.
• Collaborations between biotech companies and infant nutrition brands to increase product availability.

Regional Analysis

• North America: A leading market due to high awareness of infant nutrition, established infant formula industry, and investment in R&D for HMO products. The U.S. drives most innovation and adoption.
• Europe: Strong demand supported by stringent quality standards, advanced healthcare infrastructure, and focus on early childhood nutrition. Germany, France, and the UK are major contributors.
• Asia-Pacific: The fastest-growing region due to increasing birth rates, rising disposable incomes, and growing adoption of infant formula in countries like China, India, and Japan.
• Latin America: Moderate growth driven by expanding infant nutrition markets and increasing health awareness among urban populations.
• Middle East & Africa: Emerging demand supported by rising awareness of infant nutrition and government initiatives promoting child health.

Future Outlook

The future of the Human Milk Oligosaccharides (HMO) Market is expected to be shaped by innovation, biotechnology, and expanding applications. Manufacturers will continue to invest in research to develop cost-effective and scalable synthetic HMOs that retain the health benefits of natural compounds.

The market is also expected to expand beyond infant nutrition, with HMOs being incorporated into functional foods, dietary supplements, and adult gut health products, catering to increasing awareness of microbiome health. E-commerce and retail expansion will improve product accessibility, especially in emerging economies.

More Trending Latest Reports By Polaris Market Research:

Fluorosilicic Acid Market

Animal Feed Additives Market

Quartz Sink Market

Automotive Refinish Coating Market

Animal Feed Additives Market

Super Apps Market

Simulators Market